- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03270449
Community-based Intervention for Fibromyalgia: A Pilot Trial
7 oktober 2019 uppdaterad av: Nelly Oelke, University of British Columbia
A Multi-disciplinary, Community-based Group Intervention for Fibromyalgia: A Pilot Randomized Controlled Trial
Fibromyalgia (FM) is a multi-factorial chronic pain condition characterized by fluctuating and heterogeneous symptoms.
This leads to both reduced patient function and quality of life and consequentially, significant economic burden on the society.
Although numerous pharmaceutical and multi-treatment approaches exist, there is lack of an integrated multidisciplinary model of care for these patients.
Such a system is hypothesized to be beneficial for the patients and would help them regain function and significantly improve their quality of life.
The primary aim of this pilot clinical trial is to evaluate the effectiveness of an integrated community-based multidisciplinary model of care for FM patients in Penticton and surrounding areas.
The comprehensive 10 week intervention will provide care from a team of health care providers (psychiatrist, physiotherapist, certified exercise therapist, dietitian, rheumatologist, and mental health clinician).
Patients will also attend a peer led pain self-management support group provided by the Arthritis Society.
The study aims at educating these patients about self-management of their symptoms such as chronic pain, weight, sleep and mood disorders.
The integration of health care between the different providers will be achieved by "huddle" sessions that will be conducted on a monthly basis.
The evaluation of the study outcomes will be based on the RE-AIM framework.
Data will be collected through patient questionnaires, healthcare utilization data, and interviews with providers.
Data analysis will involve thematic analysis of qualitative data and statistical methods for quantitative data.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
84
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
British Columbia
-
Penticton, British Columbia, Kanada, V2A 4Z1
- Balfour Medical Centre
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
19 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- formal diagnosis of FM
- resident of Penticton or surrounding area
- adults, aged 19 and older
- fluent in English or bring a family member/friend to assist with translation
- capacity to provide informed consent
Exclusion Criteria:
- patients with a severe and/or chronic medical or psychiatric condition that would impact ability to participate in the intervention
- patients who are pregnant or lactating
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Multidisciplinary intervention
The 10-week intervention will include twice weekly 1-2 hours sessions with multiple professional team members to undergo education and exercise sessions.
The multidisciplinary team will consist of a rheumatologist, rheumatology nurse, dietitian, physiotherapist, a trained exercise therapist, a physiologist who specializes in pain management, a psychiatrist and a mental health clinician.
All intervention team members have expertise in working with individuals with chronic pain conditions.
General disease information, current best practices and techniques such as self-pain management, pacing, sleep hygiene, approach to a healthy lifestyle and weight loss will be discussed.
The total number of hours for the 10 week intervention is 31 hours.
|
10 week multidisciplinary education and exercise
|
Inget ingripande: Usual care
Usual care involves being referred to the local rheumatologist involved in the study.
The rheumatologist and the rheumatology nurse will see the control group patients during a one hour one on one consultation appointment.
During that time the patient's history will be taken, physical exam performed and investigations analyzed.
If a diagnosis of fibromyalgia is confirmed, the rheumatologist and nurse will counsel the patient and provide resources for self directed management.
Unless there is a concern of an alternative diagnosis, follow up will not be arranged.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Patient-perceived quality of care
Tidsram: Change from baseline in perceived quality of care at 10 weeks and 6 months
|
Patient assessment of care received as measured by the Patient Assessment of Chronic Illness Care Questionnaire
|
Change from baseline in perceived quality of care at 10 weeks and 6 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Daily function #1
Tidsram: Change from baseline in daily function at 10 weeks and 6 months
|
Physical disease and mental health related functioning as measured by Revised-Fibromyalgia Impact Questionnaire
|
Change from baseline in daily function at 10 weeks and 6 months
|
Daily function #2
Tidsram: Change from baseline in daily function at 10 weeks and 6 months
|
Mental health related functioning as measured by Hospital Anxiety and Depression scale
|
Change from baseline in daily function at 10 weeks and 6 months
|
Health care utilization (physician visits)
Tidsram: Change from baseline in physician visits at 6 months
|
Number of physician visits
|
Change from baseline in physician visits at 6 months
|
Health care utilization (emergency visits)
Tidsram: Change from baseline in emergency department visits at 6 months
|
Number of emergency department visits
|
Change from baseline in emergency department visits at 6 months
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Sleep quality
Tidsram: Change from baseline in sleep quality at 10 weeks
|
Quality of sleep as measured by Sleep scale - medical outcome scale
|
Change from baseline in sleep quality at 10 weeks
|
Sleep quality
Tidsram: Change from baseline in sleep quality at 6 months
|
Quality of sleep as measured by Sleep scale - medical outcome scale
|
Change from baseline in sleep quality at 6 months
|
Attitudes of pain
Tidsram: Change from baseline in pain attitudes at 10 weeks and 6 months
|
Measurement of pain through Survey of brief attitudes of pain
|
Change from baseline in pain attitudes at 10 weeks and 6 months
|
Irritability
Tidsram: Change from baseline in irritability at 10 weeks
|
Irritability measured by Brief Irritability Test (BITe) questionnaire
|
Change from baseline in irritability at 10 weeks
|
Irritability
Tidsram: Change from baseline in irritability at 6 months
|
Irritability measured by Brief Irritability Test (BITe) questionnaire
|
Change from baseline in irritability at 6 months
|
Patient perspectives on self-management resources
Tidsram: 10 weeks
|
Questionnaire to be administered to gather patient perspectives on self-management resources offered via hard copy, online, and social media
|
10 weeks
|
Patient perspectives on self-management resources
Tidsram: 6 months
|
Questionnaire to be administered to gather patient perspectives on self-management resources offered via hard copy, online, and social media
|
6 months
|
Provider perspectives on quality of care
Tidsram: 18 months
|
Interviews will be conducted to gather providers' perspectives on the model of care
|
18 months
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Utredare
- Huvudutredare: Michelle Teo, University of British Columbia
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Allmänna publikationer
- Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120. doi: 10.1186/ar2783. Epub 2009 Aug 10. Erratum In: Arthritis Res Ther. 2009;11(5):415.
- Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choiniere M, Ko G, Moulin DE, Panopalis P, Proulx J, Shir Y; National Fibromyalgia Guideline Advisory Panel. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013 May-Jun;18(3):119-26. doi: 10.1155/2013/918216.
- Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D, Gerwin R, Zlateva G. The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes. 2011 Aug 22;9:71. doi: 10.1186/1477-7525-9-71.
- Lachaine J, Beauchemin C, Landry PA. Clinical and economic characteristics of patients with fibromyalgia syndrome. Clin J Pain. 2010 May;26(4):284-90. doi: 10.1097/AJP.0b013e3181cf599f.
- Thompson JM, Luedtke CA, Oh TH, Shah ND, Long KH, King S, Branda M, Swanson R. Direct medical costs in patients with fibromyalgia: Cost of illness and impact of a brief multidisciplinary treatment program. Am J Phys Med Rehabil. 2011 Jan;90(1):40-6. doi: 10.1097/PHM.0b013e3181fc7ff3.
- Winkelmann A, Perrot S, Schaefer C, Ryan K, Chandran A, Sadosky A, Zlateva G. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Appl Health Econ Health Policy. 2011 Mar 1;9(2):125-36. doi: 10.2165/11535250-000000000-00000.
- Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012;2012:426130. doi: 10.1155/2012/426130. Epub 2012 Nov 4. Erratum In: Pain Res Treat. 2013;2013:960270.
- Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Am J Public Health. 2013 Jun;103(6):e38-46. doi: 10.2105/AJPH.2013.301299. Epub 2013 Apr 18.
- Richards L, Morse J. Read me first for a users guide to qualitative methods. (3rd ed.) Sage Publications, Inc. 2013.
- Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. Springer Science & Business Media; 2009.
- Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care. 2005 May;43(5):436-44. doi: 10.1097/01.mlr.0000160375.47920.8c.
- Nam S, Tin D, Bain L, Thorne JC, Ginsburg L. Clinical utility of the Hospital Anxiety and Depression Scale (HADS) for an outpatient fibromyalgia education program. Clin Rheumatol. 2014 May;33(5):685-92. doi: 10.1007/s10067-013-2377-1. Epub 2013 Sep 1.
- Cappelleri JC, Bushmakin AG, McDermott AM, Dukes E, Sadosky A, Petrie CD, Martin S. Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia. Sleep Med. 2009 Aug;10(7):766-70. doi: 10.1016/j.sleep.2008.09.004. Epub 2009 Jan 29.
- Tait RC, Chibnall JT. Development of a brief version of the Survey of Pain Attitudes. Pain. 1997 Apr;70(2-3):229-35. doi: 10.1016/s0304-3959(97)03330-7.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
15 september 2017
Primärt slutförande (Faktisk)
30 juni 2019
Avslutad studie (Faktisk)
30 juni 2019
Studieregistreringsdatum
Först inskickad
21 augusti 2017
Först inskickad som uppfyllde QC-kriterierna
31 augusti 2017
Första postat (Faktisk)
1 september 2017
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
9 oktober 2019
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
7 oktober 2019
Senast verifierad
1 oktober 2019
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- H17-01782
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Fibromyalgi
-
University of AberdeenAvslutadFibromyalgi | Fibromyalgi, primär | Fibromyalgi, sekundärStorbritannien
-
Eli Lilly and CompanyAvslutadFibromyalgi, primär | Fibromyalgi, sekundärMexiko
-
Rasmia ElgoharyHar inte rekryterat ännu
-
Spaulding Rehabilitation HospitalHar inte rekryterat ännu
-
Cairo UniversityHar inte rekryterat ännu
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases...Avslutad
-
University of UtahAvslutad
-
State University of New York - Upstate Medical...AvslutadFibromyalgi, primärFörenta staterna
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloAvslutad
Kliniska prövningar på Multidisciplinary intervention
-
Emory UniversityChildren's Healthcare of AtlantaAvslutadMatnings- och ätstörningar | Undvikande/restriktivt matintagsstörning | MatningsstörningarFörenta staterna
-
Azienda Ospedaliero-Universitaria di ParmaAvslutadBuksmärtor | Andningssvikt | Svaghet | Handikapp | Infektion | MultisjuklighetItalien
-
Karolinska University HospitalPhilips Electronics Nederland B.V. acting through Philips CTO organizationAvslutad
-
Ospedale Generale Di Zona Moriggia-PelasciniAvslutadParkinsons sjukdom och Pisa syndromItalien
-
University of WashingtonPatient-Centered Outcomes Research InstituteAktiv, inte rekryterandePTSD | Fysisk skadaFörenta staterna
-
University Hospital, BordeauxAvslutad
-
Biolux Research Holdings, Inc.AvslutadOrtodontisk tandrörelseKanada
-
University of FloridaAvslutadKänslighetFörenta staterna
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Institute on Minority Health...RekryteringHumant papillomvirusinfektionFörenta staterna
-
Roswell Park Cancer InstituteAvslutadFetma | Övervikt | Bröstcancer i anatomisk stadium I AJCC v8 | Bröstcancer i anatomiskt stadium IA AJCC v8 | Anatomiskt stadium IB Bröstcancer AJCC v8 | Anatomisk steg II bröstcancer AJCC v8 | Anatomiskt stadium IIA Bröstcancer AJCC v8 | Anatomiskt stadium IIB Bröstcancer AJCC v8 | Anatomisk steg III bröstcancer... och andra villkorFörenta staterna